← Leaderboards
Weiqiang Chen
New York University
$4,205,192
Attributed
$6,009,327
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,009,327 · 5
By mechanism
R01$2,583,527 · 1
R35$1,963,580 · 1
R21$1,462,220 · 3
Top collaborators
- Pengyu Chen5 shared
- Matija Snuderl3 shared
- Theresa Wampler Muskardin2 shared
Most similar at New York University
Same institution · by research overlap
- Aleksandar Donev$1,458,357
- Blaise Delmotte$139,995
- Michelle Driscoll$663,652
Others in their field
Other Emerging Leaders on “Immune”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,310,675
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$74,507,826
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Tony Moody · Duke University$66,767,417
Research focus
ImmuneEngineeringCellsScreeningImmunotherapyResponseImmunityPre-ClinicalMapsPatient ResponseRelapseImmunologicsIn SituTumor MicroenvironmentInsightT-Cell ActivationChimeric Antigen ReceptorChimeric Antigen Receptor T CellsHeterogeneityInnovationLeukemiaCytotoxicityCell PhysiologyBone Marrow
Grant awards (17)
Development of a Human Lymph node-on a Chip Microphysiological System for Evaluation of Vaccine Effectiveness against Infectious Diseases$437,477
R21 · FY2025 · AI · contact PI
Development of a Synovium-on-a-Chip Microphysiological System to Interrogate Pathobiology and Enhance Precision Medicine in Rheumatoid Arthritis$179,469
R21 · FY2025 · AR · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$493,522
R01 · FY2024 · CA · contact PI
Development of a Synovium-on-a-Chip Microphysiological System to Interrogate Pathobiology and Enhance Precision Medicine in Rheumatoid Arthritis$235,690
R21 · FY2024 · AR · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$510,476
R01 · FY2023 · CA · contact PI
Dissecting and engineering CAR T-cell function for optimized Immunotherapy$342,716
R35 · FY2023 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$511,811
R01 · FY2022 · CA · contact PI
Dissecting and engineering CAR T-cell function for optimized Immunotherapy$342,716
R35 · FY2022 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$523,587
R01 · FY2021 · CA · contact PI
Dissecting and engineering CAR T-cell function for optimized Immunotherapy$342,716
R35 · FY2021 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$544,131
R01 · FY2020 · CA · contact PI
Dissecting and engineering CAR T-cell function for optimized Immunotherapy$342,716
R35 · FY2020 · GM · contact PI
Purchase of spinning disk confocal microscope$250,000
R35 · FY2020 · GM · contact PI
Engineered Glioblastoma Tumor Immunity for Personalized Immunotherapy$191,878
R21 · FY2020 · EB · contact PI
Dissecting and engineering CAR T-cell function for optimized Immunotherapy$342,716
R35 · FY2019 · GM · contact PI
Engineered Glioblastoma Tumor Immunity for Personalized Immunotherapy$191,760
R21 · FY2019 · EB · contact PI
Engineered Glioblastoma Tumor Immunity for Personalized Immunotherapy$225,946
R21 · FY2018 · EB · contact PI